Anti-trypanosoma cruzi antibody profiling in patients with chagas disease treated with benznidazole assessed by genome phage display

HIGHLIGHTS

  • who: Luis Antonio Rodriguez Carnero et al. from the Department of Biochemistry, Institute of Chemistry, University of Su00e3o Paulo, Su00e3o Paulo, Brazil, Heart have published the article: Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display, in the Journal: (JOURNAL) of December/12,/2022
  • what: The gPhage library used in this study had approximate 100-fold coverage of the corresponding T. cruzi proteome . The authors show that gPhage technology can be utilized to screen and quantify the antibody response of Chagas disease patients and, in agreement . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?